HIV May Up Risk for Liver Steatosis in Mono-infected Patients

(MedPage Today) -- Earlier intervention on'manageable factors'for fatty liver disease may help in this population
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news

Related Links:

This article explores different microbiota modulation strategies for the treatment of NAFLD-NASH.Alimentary Pharmacology &Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Conditions:   NAFLD;   Bariatric Surgery Candidate Intervention:   Procedure: Bariatric Surgery Sponsor:   Assiut University Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Authors: Kiapidou S, Liava C, Kalogirou M, Akriviadis E, Sinakos E Abstract The association of non-alcoholic fatty liver disease (NAFLD) with several other diseases has gained increased interest during the recent years. Among them, the association with chronic kidney disease (CKD) has emerged as an important one regarding both its prevalence and significance. The early recognition of this association is important for the prognosis of patients with NAFLD and CKD. Apart from early diagnosis, the accurate assessment of renal function is also crucial in the clinical practice of hepatologists. Several methods have been ...
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
CONCLUSION: Our study reinforces the role of older age, obesity and hepatomegaly as predictors of fatty liver disease. These variables should be considered in the assessment of fatty changes in the livers of potential liver donors.
Source: Clinics - Category: General Medicine Source Type: research
Contributors : Birgit Knebel ; Jorg Kotzka ; Dirk M üller-WielandSeries Type : Expression profiling by arrayOrganism : Mus musculusIn non-alcoholic fatty liver disease (NAFLD) caused by ectopic lipid accumulation, lipotoxicity is a crucial molecular risk factor. Mechanisms to eliminate lipid overflow can prevent the liver from functional complications. This may involve increased secretion of lipids or metabolic adaptation to ß-oxidation in lipid-degrading organelles such as mitochondria and peroxisomes. In addition to dietary factors, increased plasma fatty acid levels may be due to increased triglyceride synthe...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by array Mus musculus Source Type: research
Abnormal levels of liver enzymes, particularly aminotransferases, are prognostic features of non-alcoholic fatty liver disease (NAFLD). Considering the important role of dietary intakes in development of NAFLD...
Source: BMC Endocrine Disorders - Category: Endocrinology Authors: Tags: Research article Source Type: research
In this study, ICR male mice were fed a high-fat diet (HFD) in vivo and the AML12 cells were treated with palmitic acid (PA) in vitro. We explore the protective effect and potential mechanism of Chinese Herbal Formula (CHF03) against NAFLD by HE staining, transmission Electron Microscopy assay, Western blotting, and gene expression. In vivo, oxidative stress markers (GSH, GSH-px, MDA, SOD, and CAT) confirmed that CHF03 alleviated oxidative stress and abundance of NF-κB proteins indicating a reduction in inflammation and oxidative stress. The lower protein abundance of ACACA and FASN indicated a preventive effect on l...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
The company started in January 2018 in Israel and moved to San Francisco this year.
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
The most common causes of chronic liver disease in the developed world —nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) — are the hepatic manifestations of an insulin-resistant state that is linked to visceral adiposity and systemic inflammation. NAFLD and NASH lead to an expansion of epicardial adipose tissue and the release of pro inflammatory adipocytokines that cause microcirculatory dysfunction and fibrosis of the adjoining myocardium, resulting in atrial fibrillation as well as heart failure with a preserved ejection fraction (HFpEF).
Source: The American Journal of Medicine - Category: General Medicine Authors: Tags: Review Source Type: research
More News: Fatty Liver Disease (FLD) | Liver | Liver Disease | Primary Care | Urology & Nephrology